Picton Mahoney Asset Management boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.8% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 23,436 shares of the company’s stock after acquiring an additional 4,202 shares during the quarter. Picton Mahoney Asset […]